Related Experiment Video
Updated: Jun 17, 2026

Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes
Published on: January 30, 2019
Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook
Siddharth Shukla1, Chintan S Sumaria, P I Pradeepkumar
1Department of Chemistry, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India.
RNA interference (RNAi) utilizes small interfering RNAs (siRNAs) for gene silencing. Recent structural data on Argonaute complexes clarifies mechanisms and guides the development of next-generation siRNA therapeutics with improved properties.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Development
Background:
- RNA interference (RNAi) is a crucial gene silencing mechanism with therapeutic potential for diseases like cancer and HIV.
- A mechanistic understanding of messenger RNA (mRNA) cleavage by the RNA-induced silencing complex (RISC) was limited by insufficient structural data.
- Argonaute (Ago)-DNA-RNA complex structures offer new insights into RNAi mechanisms.
Purpose of the Study:
- To review chemical modifications for enhancing siRNA therapeutics.
- To interpret siRNA chemical modification tolerance using structural and biochemical data of Ago-RNA complexes.
- To discuss challenges and progress in developing drug-like siRNAs and their delivery.
Main Methods:
- Analysis of X-ray crystal structures of Argonaute (Ago)-DNA-RNA complexes.
- Review of biochemical studies on Ago-RNA interactions.
- Interpretation of data regarding chemical modifications in siRNAs.
Main Results:
- Recent crystal structures provide a mechanistic understanding of mRNA cleavage by Argonaute2 within RISC.
- Structural insights guide the design of improved siRNA therapeutics.
- Understanding chemical modification tolerance is key to enhancing siRNA properties.
Conclusions:
- Structural data on Ago-RNA complexes is a breakthrough for siRNA therapeutic design.
- Chemical modifications are essential for optimizing siRNA nuclease resistance, immune response, off-target effects, and pharmacokinetics.
- Further research is needed to overcome challenges in siRNA drug-likeness and delivery.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
RNA Structure
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...
Types of RNA
RNA Performs Diverse...
RNA Editing
